Cancer Immunotherapy Drug Discovery Outsourcing Market
According to Intent Market Research, the Cancer Immunotherapy Drug Discovery Outsourcing Market is expected to grow from USD 4.0 billion in 2023 at a CAGR of 15.9% to touch USD 11.2 billion by 2030. The Cancer Immunotherapy Drug Discovery Outsourcing Market is dominated by key players such as Eli Lilly and Company, Bristol-Myers Squibb, Merck & Co., Inc., Roche Holding AG, Pfizer Inc., AstraZeneca, Novartis International AG, Johnson & Johnson, AbbVie Inc., Gilead Sciences, Inc., Sanofi S.A., Amgen Inc., Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc, Bayer AG.